Institution
Cancer Research UK Cambridge Center
Recent research
- BiologyOpen access
Abstract Tumour-promoting inflammation and immune evasion are key features of cancer, but prospective evidence linking specific immune pathways to prostate cancer risk remains limited. Here we show that circulating proteins involved in immune regulation may influence prostate can...
- BiologyOpen access
Window of opportunity (WOO) trials are short, pre-surgical trials which aim to evaluate novel therapeutic strategies and answer biological and mechanistic questions. Despite their relative simplicity, their conduct can be challenging. This Perspectives Article considers key facto...
- BiologyOpen access
Spatially resolved multiomics of human meningeal development reveal lineage and disease dynamics
Abstract The meninges are increasingly recognized as key stromal and immune niches supporting cranial development. Here we constructed a paired single-nuclei RNA and Assay for Transposase-Accessible Chromatin atlas of human meningeal development from 6 to 21 postconception weeks...
- BiologyOpen access
ABSTRACT Urinary cell‐free DNA (cfDNA) is a promising substrate for non‐invasive liquid biopsy analysis and biomarker detection. However, the lack of standardized pre‐analytical workflows and the intrinsic challenges associated with isolating highly dilute and fragmented cfDNA li...
- Health & MedicineOpen access
Background. High-grade serous ovarian carcinoma (HGSOC) causes most deaths from ovarian cancer, and treatment remains largely empirical outside the homologous-recombination-deficient subgroup. Genomic, immune, stromal and treatment-induced states with different therapeutic vulner...
- Health & MedicineOpen access
BACKGROUND: Pharmacological cancer risk reduction has received far less investment than therapeutic oncology and only a few agents have entered routine practice. Understanding the predictors of positive outcomes of previous trials and issues faced is critical to future developmen...
- Health & MedicineOpen access
Abstract Interactions between epithelial cells and fibroblasts influence disease progression and treatment response in pancreatic ductal adenocarcinoma (PDAC). While the diversity of fibroblasts in PDAC is increasingly recognized, it remains unclear how these cells differ from fi...